Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: Part II

Journal of Vascular and Interventional Radiology

Volumn 12, Issue 7, 2001, Pages 807-812

  Kandarpa, Krishna ^a   Becker, Gary J ^b   Ferguson, Robert D G ^c   Connors, J J ^d   Wojak, Joan C ^e   Landow, Wendy J ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^c KINGSTON GENERAL HOSPITAL   (Canada)

^d INOVA FAIRFAX HOSPITAL   (United States)

^e LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^f Society for Interventional Radiology   (United States)

Author keywords

Angioplasty; Arteries, peripheral; Arteriosclerosis; Stents and prostheses

Indexed keywords

FIBRINOLYTIC AGENT;

ANGIOPLASTY; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SAFETY; STROKE;

EID: 0034944250     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61504-8     Document Type: Review

References (75)

1. Image-guided transcatheter interventions for the treatment of peripheral atherosclerotic lesions
2. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis
3. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-90%) or mild (0-29%) stenosis
4. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis
5. Benefit of carotid endarterectomy in Patients with symptomatic moderate or severe stenosis
6. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: Systematic review
7. Carotid endarterectomy outcome is not affected in patients with a contralateral carotid artery occlusion
8. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis
9. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: A stopped trial
10. Carotid stent-supported angioplasty: A neurovascular intervention to prevent stroke
11. Carotid artery intervention
12. Angioplasty and stenting of the extracranial carotid arteries
13. Endovascular stents for carotid artery occlusive disease
14. Stenting in the carotid artery: Initial experience in 110 patients
15. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy
16. Getting it right the first time
17. Brain damage during cardiopulmonary bypass
18. Long-term neurologic outcome after cardiac operation
19. Unruptured intracranial aneurysms - Risk of rupture and risks of surgical intervention
20. Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement
21. Ex vivo human carotid artery bifurcation stenting: Correlation of lesion characteristics with embolic potential
22. New triple coaxial catheter system for carotid angioplasty with cerebral protection
23. Carotid recurrent stenosis and risk of ipsilateral stroke: A systematic review of the literature
24. Recurrent carotid stenosis after carotid endarterectomy
25. The clinical and pathologic spectrum of recurrent carotid stenosis
26. Carotid stenting in 350 vessels: Problems faced and solved
27. Carotid angioplasty
28. Carotid stenting and angioplasty: A statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology, and Prevention, and Clinical Cardiology, American Heart Association
29. Concern about safety of carotid angioplasty
30. Carotid angioplasty and stent: An alternative to carotid endarterectomy
31. Cerebral fibrinolysis at the crossroads
32. The proper study of fibrinolysis is
33. Carotid endarterectomy vs carotid angioplasty
34. Prediction of benefit from carotid endarterectomy in individual patients: A risk-modeling study
35. Trials of streptokinase in severe acute ischemic stroke
36. Streptokinase in acute ischemic stroke
37. Thrombolytic therapy with streptokinase in acute ischemic stroke
38. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS)
39. Tissue plasminogen activator for acute ischemic stroke
40. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
41. PROACT II: Recombinant prourokinase (r-pro-UK) in acute cerebral thromboembolism: Initial trial results
42. The warfarin-aspirin symptomatic intracranial disease study
43. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: The Northern Manhattan Stroke Study
44. Race and sex differences in the distribution of cerebral atherosclerosis
45. Importance of carotid plaque in determining symptoms of cerebral ischemia
46. Detection of intracranial emboli in patients with carotid disease
47. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation
48. Do chronic middle cerebral artery stenoses represent an embolic focus? A multirange transcranial Doppler study
49. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease
50. Occlusive disease of the middle cerebral artery
51. Intracranial internal carotid artery stenosis
52. Intracranial internal carotid artery stenosis: Long-term prognosis
53. Prognosis of patients with symptomatic vertebral or basilar artery stenosis
54. The natural history of isolated carotid siphon stenosis
55. Atherosclerotic diseases of the middle cerebral artery
56. Failure of extracranial-intracranial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial
57. Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow
58. Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis
59. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries
60. Balloon angioplasty of intracranial arteries for stroke prevention
61. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis
62. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries
63. Outcome of angioplasty for atherosclerotic intracranial stenosis
64. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results
65. Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions
66. Percutaneous transluminal cerebral angioplasty: Serial angiographic follow-up after successful dilatation
67. Vertebral artery stenting following percutaneous transluminal angioplasty: Technical note
68. Percutaneous transluminal angioplasty of atherosclerotic basilar artery stenosis
69. Percutaneous transluminal angioplasty for total occlusion of middle cerebral arteries
70. Intracranial angioplasty: Experience and complications
71. Pilot study for cerebral balloon angioplasty: Design considerations and case-control methods
72. The role of angioplasty in the treatment of cerebrovascular disease
73. Stenting of symptomatic stenosis of the intracranial internal carotid artery
74. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis